These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30213396)

  • 21. Mantle cell lymphoma in patients not eligible for autologous stem cell transplantation.
    Aurer I
    Curr Opin Oncol; 2019 Sep; 31(5):374-379. PubMed ID: 31233483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma.
    Merryman RW; Edwin N; Redd R; Bsat J; Chase M; LaCasce A; Freedman A; Jacobson C; Fisher D; Ng S; Crombie J; Kim A; Odejide O; Davids MS; Brown JR; Jacene H; Cashen A; Bartlett NL; Mehta-Shah N; Ghobadi A; Kahl B; Joyce R; Armand P; Jacobsen E
    Blood Adv; 2020 Mar; 4(5):858-867. PubMed ID: 32126141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
    Dawar R; Hernandez-Ilizaliturri F
    Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation.
    Nazeef M; Kahl BS
    Curr Treat Options Oncol; 2015 Jun; 16(6):29. PubMed ID: 25975443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?
    Chaudhary L; Kharfan-Dabaja MA; Hari P; Hamadani M
    Bone Marrow Transplant; 2013 Nov; 48(12):1489-96. PubMed ID: 23584438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mantle Cell Lymphoma.
    Cheah CY; Seymour JF; Wang ML
    J Clin Oncol; 2016 Apr; 34(11):1256-69. PubMed ID: 26755518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma.
    Mussetti A; Kumar A; Dahi PB; Perales MA; Sauter CS
    Blood Rev; 2015 May; 29(3):143-52. PubMed ID: 25468719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment for mantle cell lymphoma].
    Izutsu K
    Rinsho Ketsueki; 2017; 58(10):2026-2032. PubMed ID: 28978845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New strategies in the treatment of mantle cell lymphoma.
    Deng C; Lee S; O'Connor OA
    Clin Cancer Res; 2012 Jul; 18(13):3499-508. PubMed ID: 22700864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose cytarabine in mantle cell lymphoma.
    Martin P
    Clin Adv Hematol Oncol; 2015 Oct; 13(10):646-9. PubMed ID: 27058567
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies.
    Zaja F; Federico M; Vitolo U; Zinzani PL
    Leuk Lymphoma; 2014 May; 55(5):988-98. PubMed ID: 23865835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing therapy for mantle cell lymphoma.
    Martin P
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):304-309. PubMed ID: 29222271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current therapeutic strategies for mantle cell lymphoma].
    Dreyling M; Schnaiter A; Schmidt C; Hoster E
    Internist (Berl); 2016 Mar; 57(3):230-7. PubMed ID: 26886710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse aggressive lymphoma.
    Fisher RI; Miller TP; O'Connor OA
    Hematology Am Soc Hematol Educ Program; 2004; ():221-36. PubMed ID: 15561685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful use of cytarabine and bendamustine in a patient with mantle cell lymphoma and acute renal failure using intermittent hemodialysis: A case report.
    Ettleson M; Bongers KS; Vitale K; Perissinotti AJ; Phillips T; Marini BL
    J Oncol Pharm Pract; 2019 Apr; 25(3):731-734. PubMed ID: 29385883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
    Le Gouill S; Thieblemont C; Oberic L; Moreau A; Bouabdallah K; Dartigeas C; Damaj G; Gastinne T; Ribrag V; Feugier P; Casasnovas O; Zerazhi H; Haioun C; Maisonneuve H; Houot R; Jardin F; Van Den Neste E; Tournilhac O; Le Dû K; Morschhauser F; Cartron G; Fornecker LM; Canioni D; Callanan M; Béné MC; Salles G; Tilly H; Lamy T; Gressin R; Hermine O;
    N Engl J Med; 2017 Sep; 377(13):1250-1260. PubMed ID: 28953447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mantle Cell Lymphoma: Current and Emerging Treatment Strategies and Unanswered Questions.
    Diamond B; Kumar A
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):613-626. PubMed ID: 31229158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous Stem Cell Transplant: Still the Standard for Fit Patients With Mantle Cell Lymphoma.
    Staton AD; Langston AA
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S96-S99. PubMed ID: 28760309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mantle cell lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJM; Dreyling M
    Crit Rev Oncol Hematol; 2020 Sep; 153():103038. PubMed ID: 32739830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.